MNOV Financial Facts

Net loss applicable to common stockholders: -2.12M
Total operating expenses: 2.13M
See Full Income Statement

See Full Balance Sheet

Medicinova, Inc. (MNOV) Earnings

  |   Expand Research on MNOV
Next EPS Date N/A EPS Growth Rate +28.6% *Last Qtr.
Average EPS % Beat Rate +2.0% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -10.9% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/16/11 Q111 -$0.45N/A N/A N/AN/A N/A Details
8/16/11 Q211 -$0.31-$0.33 +$0.02N/AN/A N/A Details
11/15/11 Q311 -$0.25-$0.29 +$0.04N/AN/A N/A Details
5/10/12 Q112 -$0.24-$0.28 +$0.04N/AN/A N/A Details
3/29/12 Q411 -$0.22-$0.24 +$0.02N/AN/A N/A Details
11/8/12 Q312 -$0.14N/A N/A N/AN/A N/A Details
5/8/13 Q113 -$0.14-$0.13 -$0.01N/A$310K N/A Details
8/8/13 Q213 -$0.14-$0.11 -$0.03N/A$370K N/A Details